In STZ-treated rats, diabetes lowered Glo1 activity and upregulated some AGE markers (3-deoxyglucosone (3-DG) and CML) but had no impact on MGO and CEL levels in the rats’ hearts [167]. The gene discussed is GLO1; the disease is diabetes mellitus.